Literature DB >> 1955954

Candida haemulonii from clinical specimens in the USA.

I B Gargeya1, W R Pruitt, S A Meyer, D G Ahearn.   

Abstract

Classical yeast identification procedures and DNA relatedness studies confirmed the occurrence of Candida haemulonii among clinical specimens in the USA, particularly isolations from the foot. None of the six clinical isolates studied produced identical API 20C profile codes.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1955954

Source DB:  PubMed          Journal:  J Med Vet Mycol        ISSN： 0268-1218


  11 in total

1.  Transient fungemia caused by an amphotericin B-resistant isolate of Candida haemulonii.

Authors:  Laura Rodero; Manuel Cuenca-Estrella; Susana Córdoba; Pedro Cahn; Graciela Davel; Sara Kaufman; Liliana Guelfand; Juan L Rodríguez-Tudela
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Prevalence of Candida ciferrii in elderly patients with trophic disorders of the legs.

Authors:  L de Gentile; J P Bouchara; C Le Clec'h; B Cimon; F Symoens; D Chabasse
Journal:  Mycopathologia       Date:  1995-08       Impact factor: 2.574

Review 3.  New and emerging yeast pathogens.

Authors:  K C Hazen
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

4.  Unrelatedness of groups of yeasts within the Candida haemulonii complex.

Authors:  P F Lehmann; L C Wu; W R Pruitt; S A Meyer; D G Ahearn
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

5.  Fluconazole-Resistant Candida auris Is Susceptible to Salivary Histatin 5 Killing and to Intrinsic Host Defenses.

Authors:  Ruvini U Pathirana; Justin Friedman; Hannah L Norris; Ornella Salvatori; Andrew D McCall; Jason Kay; Mira Edgerton
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

6.  Outbreak of fungemia among neonates caused by Candida haemulonii resistant to amphotericin B, itraconazole, and fluconazole.

Authors:  Zia U Khan; Noura A Al-Sweih; Suhail Ahmad; Nawal Al-Kazemi; Seema Khan; Leena Joseph; Rachel Chandy
Journal:  J Clin Microbiol       Date:  2007-04-11       Impact factor: 5.948

7.  Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts.

Authors:  E Cendejas-Bueno; A Kolecka; A Alastruey-Izquierdo; B Theelen; M Groenewald; M Kostrzewa; M Cuenca-Estrella; A Gómez-López; T Boekhout
Journal:  J Clin Microbiol       Date:  2012-09-05       Impact factor: 5.948

8.  Catheter-related candidemia caused by Candida haemulonii in a patient in long-term hospital care.

Authors:  Sunyong Kim; Kwan Soo Ko; Su Yeon Moon; Mi Suk Lee; Mi Young Lee; Jun Seong Son
Journal:  J Korean Med Sci       Date:  2011-01-24       Impact factor: 2.153

9.  First Genome Sequences of Two Multidrug-Resistant Candida haemulonii var. vulnera Isolates From Pediatric Patients With Candidemia.

Authors:  Luiza Souza Rodrigues; Rajesh Kumar Gazara; Hemanoel Passarelli-Araujo; Andressa Eloisa Valengo; Paula Veronesi Marinho Pontes; Rodrigo Nunes-da-Fonseca; Robson Francisco de Souza; Thiago Motta Venancio; Libera Maria Dalla-Costa
Journal:  Front Microbiol       Date:  2020-07-03       Impact factor: 5.640

10.  In vivo Activity of Copper(II), Manganese(II), and Silver(I) 1,10-Phenanthroline Chelates Against Candida haemulonii Using the Galleria mellonella Model.

Authors:  Rafael M Gandra; Pauraic McCarron; Livia Viganor; Mariana Farias Fernandes; Kevin Kavanagh; Malachy McCann; Marta H Branquinha; André L S Santos; Orla Howe; Michael Devereux
Journal:  Front Microbiol       Date:  2020-03-24       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.